JPS61282085A - Exogenote bpha-c having biphenyl metabolic function and novel microorganism having said exogenote bpha-c - Google Patents
Exogenote bpha-c having biphenyl metabolic function and novel microorganism having said exogenote bpha-cInfo
- Publication number
- JPS61282085A JPS61282085A JP60124555A JP12455585A JPS61282085A JP S61282085 A JPS61282085 A JP S61282085A JP 60124555 A JP60124555 A JP 60124555A JP 12455585 A JP12455585 A JP 12455585A JP S61282085 A JPS61282085 A JP S61282085A
- Authority
- JP
- Japan
- Prior art keywords
- strain
- biphenyl
- bacteria
- bpha
- exogenote
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
(イ)本発明はビフェニル代謝機能を有するシュウトモ
ナス・シュウ、本遺伝子は、例えば増殖能の高いシュウ
トモナス・プチダ(Pseudomonas put
ida)やシュウトモナス・エルギノーザ(Pseud
omonas aeruginosa)等に組換え形
質転換させた微生物を用いて化合物■2−ハイドロキシ
−6−オキソ−6−フェニルヘキサ−2,4−ジェノイ
ックアシッド及びその誘導体を製造せしめ、病源菌とし
て知られている例えばスタフィロコッカス属などのグラ
ム陽性菌及び大腸菌などのダラム陰性菌に対する殺菌剤
や生理活性物質の中間体としての生産に寄与できること
が期待されるものである。DETAILED DESCRIPTION OF THE INVENTION (a) The present invention relates to Pseudomonas putida having a biphenyl metabolic function.
ida) and Shutomonas aeruginosa (Pseud
The compound (1) 2-hydroxy-6-oxo-6-phenylhexa-2,4-genoic acid and its derivatives were produced using microorganisms recombinantly transformed into S. omonas aeruginosa), which are known as pathogenic bacteria. It is expected that the present invention can contribute to the production of bactericidal agents and physiologically active substance intermediates against Gram-positive bacteria such as Staphylococcus and Durham-negative bacteria such as Escherichia coli.
(ロ)従来の技術
従来、ビフェニルを資化する細菌については数種類分離
され、その代謝様式も検討されているが、遺伝子単位で
検討された例は知られていない。(b) Conventional technology Several types of bacteria that assimilate biphenyl have been isolated and their metabolic modes have been studied, but no examples of studies on gene-by-gene basis are known.
また、ビフェニルの特定の中間代謝物については代謝様
式を含めて遺伝子単位で検討された例はない。Furthermore, there has been no study of specific intermediate metabolites of biphenyl on a gene-by-gene basis, including the metabolic mode.
そこで、本発明者らはビフェニル代謝機構に関連する遺
伝子について研究を進めた結果、シュウドモナス・シュ
ウドアルカリゲネス由来の遺伝子bph A−Cをと
り出すことに成功し、本発明を完成するに至った。Therefore, the present inventors conducted research on genes related to biphenyl metabolic mechanism, and as a result, succeeded in extracting genes bph A-C derived from Pseudomonas pseudoalcaligenes, and completed the present invention.
(ハ)発明の構成
KF707) (FERM P−8297)を例示
できる。(c) Structure of the invention KF707) (FERM P-8297) can be exemplified.
なお、本菌株の菌学的性質は以下のとおりである。The mycological properties of this strain are as follows.
ダラム 陰性
桿菌 0.7X1.5〜2.0μ極鞭毛
1本
色素産生 なし
オキシダーゼ 陽性
スターチ加水分解 陰性
41℃での生育 陽性
最適生育温度 35℃
資化性 グルコース、こはく酸、乳酸、
ピルビン酸以上の菌学的性質からバージイーズ マニュ
アル オブ システィなお、本菌株は、新規な外来遺伝
子bph A−Cを保有する点で新規な微性物である
。Durham negative bacillus 0.7X1.5~2.0μ polar flagella
1 Pigment production None Oxidase Positive Starch hydrolysis Negative Growth at 41℃ Positive Optimum growth temperature 35℃ Assimilation Glucose, succinic acid, lactic acid,
This strain is a novel microorganism in that it possesses the novel foreign genes bph A-C.
本菌株からの該遺伝子の切出しは、前記菌株を例えばL
培地(バクトリプトン10g、イーストエキス5g、食
塩5g、蒸溜水it)に−晩増殖させ、リゾチーム−3
DS法により溶菌し染色体DNAを調製し、次いで、染
色体DNA (1μg)を制限酵素XhoTで切断する
ことにより、本遺伝子を得ることができる。Excision of the gene from the present strain can be performed by converting the strain to, for example, L
Lysozyme-3 was grown late in a medium (10 g of bactryptone, 5 g of yeast extract, 5 g of salt, and 100 g of distilled water).
The present gene can be obtained by preparing chromosomal DNA by lysis using the DS method, and then cleaving the chromosomal DNA (1 μg) with the restriction enzyme XhoT.
本遺伝子の各種制限酵素による切断数は第1表に示すと
おりである。The number of cleavages of this gene by various restriction enzymes is shown in Table 1.
(>゛AT−酪臼)
第1表
また、本遺伝子の断片の制限酵素地図は第1図に示され
るとおりである。(>゛AT-dairy mill) Table 1 Furthermore, the restriction enzyme map of the fragment of this gene is as shown in FIG.
次に、本遺伝子のビフェニル代謝様式と遺伝子群との関
係は次に示すとおりである。Next, the relationship between the biphenyl metabolic mode of this gene and the gene group is as shown below.
! ■ ■
■P iP& 八 kk6 611
(?上記反応式において、A、B、Cは反応を司る酵素
を示し、Aはビフェニル オキシゲナーゼ、Bはジヒド
ロキシジオール デヒドロゲナー九〇はフェニルカテコ
ール オキシゲナーゼを各々示している。! ■ ■
■P iP & eight kk6 611
(?In the above reaction formula, A, B, and C represent enzymes that control the reaction, A represents biphenyl oxygenase, B represents dihydroxydiol dehydrogenase, and 90 represents phenylcatechol oxygenase.
また、これらの酵素に対応する遺伝子として、bphA
、bphB。In addition, bphA is a gene corresponding to these enzymes.
,bphB.
bphCが存在しこれらの遺伝子はオペロンを形成して
いる。またPはプロモーターを示す。bphC exists, and these genes form an operon. Moreover, P represents a promoter.
本遺伝子の利用にあたっては、例えば、大腸菌エシェリ
ヒア・コリ’KF637(Escherichia
coli KF637)’(FERM P−829
6)由来のpKF330を常法により該菌株より取り出
した後、制限酵素Xholで切断後T4リガーゼで結合
さく1−
マイ°シン耐性遺伝子部位にはXholなどの挿入失活
部位ををしており、またカナマイシンのプロモーターを
利用できる。When using this gene, for example, Escherichia coli 'KF637 (Escherichia coli
coli KF637)' (FERM P-829
6) The derived pKF330 was extracted from the strain using a conventional method, cut with the restriction enzyme Xhol, and ligated with T4 ligase. Also, the promoter of kanamycin can be used.
次に宿主株として増殖能の高いシュウトモナス・プチダ
KF107(Psaudomonasputida
KF107)(FERM P−8294)やシュウト
モナス・エルギノーザKF204 (Pseudomo
nas aeruginosa KF204)など
を例示できる。形質転換方法及び形質転換体の選択にあ
たっては、該菌株等を対数増殖期(5X10” 細胞
/ m I! )まで培養し、集菌、洗浄後、冷バッフ
ァー (10mM MOPS−10mM RbCf
−100mM MgC1z 、pH7,0)に懸濁し
、次いで遠心後、冷バッフy−II(100mM M
OPS−10mM RbC1−100mM CaC
1z 、pH6,5)に再懸濁し0℃、30分インキエ
ベートする。次に遠心後、菌株を1/10量の冷バッフ
ァー■に懸濁する。この0. 2mj!コンピテントセ
ルに組換えプラスミド(0,5、′−
地上でpKF330及び組換えプラスミドを保有する形
質転換体を1次スクリーニングする。ビフェニル遺伝子
を保存する目的とする形質i喚体(組換え微生物)は2
.3−ジヒドロキシビフェニル溶液(’4mg/ml)
を−次スクリーニングで生じたコロニーに噴霧すること
により黄変するコロニーを選択する。ビフェニル代謝遺
伝子を含むクローンはビフェニル及びビフェニル関連化
合物より黄色物質を蓄積させ、黄色物質を酸性下(pH
1〜2)で酢酸エチルで抽出後、トリチルシリル化して
GC−MSによる分析を行いこれが化合物■(図4)及
びその誘導体であることを確認する。Next, we used Psaudomonas putida KF107 (Psaudomonas putida), which has high growth ability, as a host strain.
KF107) (FERM P-8294) and Pseudomonas aeruginosa KF204 (Pseudomonas aeruginosa)
nas aeruginosa KF204). For the transformation method and selection of transformants, the strain was cultured to the logarithmic growth phase (5 x 10" cells/ml!), harvested, washed, and then incubated with cold buffer (10mM MOPS-10mM RbCf).
-100mM MgC1z, pH 7,0), then centrifuged, and then suspended in cold buffer y-II (100mM MgClz, pH 7,0).
OPS-10mM RbC1-100mM CaC
1z, pH 6.5) and incubate for 30 minutes at 0°C. Next, after centrifugation, the bacterial strain is suspended in 1/10 volume of cold buffer ■. This 0. 2mj! Inject the recombinant plasmid (0,5,'-) into competent cells and perform the primary screening for transformants carrying pKF330 and the recombinant plasmid on the ground. is 2
.. 3-dihydroxybiphenyl solution ('4mg/ml)
- Select colonies that turn yellow by spraying the colonies generated in the next screening. Clones containing biphenyl metabolism genes accumulate more yellow substances than biphenyl and biphenyl-related compounds, and the yellow substances accumulate under acidic conditions (pH
After extraction with ethyl acetate in steps 1 and 2), the mixture was tritylsilylated and analyzed by GC-MS to confirm that it was compound (1) (FIG. 4) and its derivatives.
(ニ)実施例
実施例1
ビフェニル資化性菌シュウトモナス・シェウドアルカリ
ゲネスKF707株(FERM P−8297)をL
培地で一晩培養し、集菌、洗浄後、0.1Mトリス(p
H7,9) 、1mM EDTA バッファーに懸
濁する0次にリゾチームを最P−濃度2μg / m
12になるよう(−加え、室温で5分間インキュベート
し、10%SDSを50μ417 m lになるように
加え溶菌した。(D) Examples Example 1 The biphenyl-assimilating bacterium Shutomonas schoed alcaligenes strain KF707 (FERM P-8297) was
After culturing overnight in a medium, collecting bacteria and washing, 0.1M Tris (p
H7,9), suspend lysozyme in 1mM EDTA buffer at a maximum P-concentration of 2μg/m
12 (-), incubated at room temperature for 5 minutes, and lysed by adding 10% SDS to a total volume of 50μ417ml.
次いでプロナーゼ、RNa s e処理をしたのちフェ
ノール抽出を行い、エーテルでフェノールを除去した。Next, after treatment with pronase and RNase, phenol extraction was performed, and phenol was removed with ether.
このようにして調製したDNAは10mMトリス、1m
M EDTA バッファーに透析した。The DNA thus prepared was prepared in 10mM Tris, 1mM
Dialyzed into MEDTA buffer.
一方、プラスミドpKF330を有するエシェリヒア・
コリKF6した。次いで組換えプラスミドを宿主株であ
るシュウトモナス・エルギノーザKF204 (FE
RM P−8295)に導入した。すなわち、対数増
殖期(約4X10’セル/ m j! )のKF204
株を集菌し、等量の冷バッフy−(10mM MOP
S、10mM RbCj!。On the other hand, Escherichia harboring plasmid pKF330
Cori KF6. The recombinant plasmid was then transferred to the host strain Shutomonas aeruginosa KF204 (FE
RM P-8295). i.e., KF204 in logarithmic growth phase (approximately 4 X 10' cells/m j!)
Harvest the strain and add an equal volume of cold buff y-(10mM MOP
S, 10mM RbCj! .
100mM MgC1t 、pH7,0)で洗浄後、
冷バッフy−11(100mM MOPS、10mM
RbCj!、100mM CaC1z。After washing with 100mM MgClt, pH 7,0),
Cold buff Y-11 (100mM MOPS, 10mM
RbCj! , 100mM CaC1z.
pH6,5)に再懸濁し、0℃にて30分間放置した。pH 6.5) and left at 0°C for 30 minutes.
次に遠心後、1/10量の冷バッファー■に再懸濁し、
その0.2ml細胞懸濁液と精製したpMFBl(0,
5μg)と0℃、1時間インキュベートした。42℃で
2分間、ヒートショックした後、3mlのし培地を加え
30°Cで3時間培養した。ビフェニル代謝遺伝子群(
bph A−C)の組込まれたpMFBlを保有する
形質転換体はストレプトマイシン(200μg/mf)
を含むL−寒天培地で2,3−ジヒドロキシビフェニル
溶液(1mg/rrl )を噴霧して黄色となすると7
.9kbのbph A−C遺伝子が切り出された0本
遺伝子は第1図に示す制限酵素切断点を有していた。Next, after centrifugation, resuspend in 1/10 volume of cold buffer ■,
The 0.2 ml cell suspension and purified pMFBl (0,
5 μg) at 0° C. for 1 hour. After heat shock at 42°C for 2 minutes, 3ml of medium was added and cultured at 30°C for 3 hours. Biphenyl metabolism gene group (
Transformants carrying pMFBl integrated with bph A-C) were treated with streptomycin (200 μg/mf).
When a 2,3-dihydroxybiphenyl solution (1 mg/rrl) was sprayed on an L-agar medium containing 7
.. The 0 genes from which the 9 kb bph A-C gene was excised had the restriction enzyme cleavage points shown in FIG.
・、)
実施例2
’+1
、′実施例1で調製した組換えプラスミドpMFB1を
用いて、シュウ“ド゛モナス・プチダKF107 (F
ERM P−8294)を実施例1の方法によって形
質転換した。その結果、lXl0’セル/μgDN炭素
源としてこはく酸(1mg/mj! )i含むBSM寒
天培地に塗布(tFIl) Lヒフェニル粉末をペトリ
皿のふたにおし〕でビニールテープでシールした。KF
257株の増殖とともにビフェニル蒸気をとり込んだ菌
体は、ビフェニルを化合物■に変化せしめ、培地は鮮や
かに黄変した。・,) Example 2 '+1,' Using the recombinant plasmid pMFB1 prepared in Example 1, "domonas putida KF107 (F
ERM P-8294) was transformed by the method of Example 1. As a result, 1X10' cells/μg DN was applied on a BSM agar medium containing succinic acid (1 mg/mj!) as a carbon source (tFIl). Hyphenyl powder was placed on the lid of a Petri dish and sealed with vinyl tape. KF
As the 257 strain grew, the bacterial cells that took in the biphenyl vapor converted biphenyl to compound (■), and the medium turned bright yellow.
上記の反応はpMFBlを保有しない宿主株シュウトモ
ナス・エルギノーザKF204 (FERM P−8
295>では全く認められなかった。以上の反応はpM
FBlを保存するシュウトモナス・プチダKF138に
おいても同様に認められた。The above reaction was performed using the host strain Shutomonas aeruginosa KF204 (FERM P-8), which does not carry pMFBl.
295>, it was not recognized at all. The above reaction is pM
A similar finding was observed in Shutomonas putida KF138, which preserves FBl.
なお、宿主株及びpMFBlを保有するKF257株に
ついてダラム染色 陰性
鞭毛 1本
、細胞の大きさ 0.5−0.7X2.0
最適生育塩度 37℃
青色色素(ビオシアニン) 生成
オキシダーゼ +
GC含量 67%
以上の性質等によりKF257株はシュウトモナス・エ
ルギノーザであることを確認した。In addition, for the host strain and KF257 strain carrying pMFBl, Durham staining negative flagellum 1, cell size 0.5-0.7X2.0
Optimum growth salinity: 37°C Blue pigment (biocyanin): Generated oxidase + GC content: 67% or more.The KF257 strain was confirmed to be Shutomonas aeruginosa.
また、宿主株及びpMFBTを保有するKF138株に
ついてダラム染色 陰性
鞭毛 〉1
ビオシアニン 生成せず
螢光色素 生成
至適生育温度 25−30℃
オキシダーゼ +
GCC含量 60%
でんぷん加水分解 十
以上の性質等によりKF138株はシュウトモナス・プ
チダであるハイドロキシ−6−オキソ−6−フェニルヘ
キサ−2,4−ジェノイックアシッド及びその誘導体を
安価に製造することが可能となる。In addition, for the host strain and KF138 strain carrying pMFBT, Durham staining Negative flagella 〉1 Biocyanin No fluorescent pigment formation Optimum growth temperature 25-30℃ Oxidase + GCC content 60% Starch hydrolysis KF138 due to more than 10 properties, etc. The strain Shutomonas putida makes it possible to produce hydroxy-6-oxo-6-phenylhexa-2,4-genoic acid and derivatives thereof at low cost.
第1図は外来遺伝子bph A−Cの制限酵素切断地
図を示す。
第2図はエシエリヒヤ・コリ由来のプラスミドpKF3
30の構造を示す。
第3図は組換えプラスミドpMFB1の作製手順とその
構造を示す。
特許出願人 工業技術院長 等々力 達q)
[6°L −一一一一一一一一−−−Pst工
EcoR工
Sac工FIG. 1 shows a restriction enzyme cleavage map of the foreign genes bph A-C. Figure 2 shows plasmid pKF3 derived from Escherichia coli.
30 structures are shown. FIG. 3 shows the procedure for producing recombinant plasmid pMFB1 and its structure. Patent applicant Tatsu Todoroki, Director of the Agency of Industrial Science and Technology)
[6°L -1111111---Pst Engineering EcoR Engineering Sac Engineering
Claims (1)
フェニル代謝機能を有する外来遺伝子であって、分子量
が7.9キロベースであり、次の制限酵素において塩基
の切断数が特徴づけられる外来遺伝子 Pst I ,6個 BglII,1 Xho I 1 EcoR I ,2 BamH I ,1 Xba I 0 Sma I ,1 Sac I ,1 HindIII 0 Sal I ,0 Hpa I ,0 2)シュウドモナス・シュウドアルカリゲネス由来のビ
フェニル代謝機能を有する外来遺伝子であって、分子量
が7.9キロベースであり、次の制限酵素において塩基
の切断数が特徴づけられる外来遺伝子 Pst I ,6個 BglII,1 Xho I 1 EcoR I ,2 BamH I ,1 Xba I 0 Sma I ,1 Sac I ,1 HindIII 0 Sal I ,0 Hpa I ,0 を保有する新規な微生物シュウドモナス・シュウドアル
カリゲネスKF707株。[Scope of Claims] 1) A foreign gene having a biphenyl metabolic function derived from Pseudomonas pseudoalcaligenes, which has a molecular weight of 7.9 kilobases and is characterized by the number of bases cleaved with the following restriction enzymes: Genes Pst I, 6 BglII, 1 Xho I 1 EcoR I, 2 BamH I, 1 Xba I 0 Sma I, 1 Sac I, 1 HindIII 0 Sal I, 0 Hpa I, 0 2) Genes derived from Pseudomonas pseudoalcaligenes Foreign genes with biphenyl metabolism function, which have a molecular weight of 7.9 kilobases and are characterized by the number of bases cleaved with the following restriction enzymes: Pst I, 6 BglII, 1 Xho I 1 EcoR I, A novel microorganism Pseudomonas pseudoalcaligenes KF707 strain harboring 2 BamH I , 1 Xba I 0 Sma I , 1 Sac I , 1 HindIII 0 Sal I , 0 Hpa I , 0 .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60124555A JPS61282085A (en) | 1985-06-08 | 1985-06-08 | Exogenote bpha-c having biphenyl metabolic function and novel microorganism having said exogenote bpha-c |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60124555A JPS61282085A (en) | 1985-06-08 | 1985-06-08 | Exogenote bpha-c having biphenyl metabolic function and novel microorganism having said exogenote bpha-c |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61282085A true JPS61282085A (en) | 1986-12-12 |
| JPH0336515B2 JPH0336515B2 (en) | 1991-05-31 |
Family
ID=14888376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60124555A Granted JPS61282085A (en) | 1985-06-08 | 1985-06-08 | Exogenote bpha-c having biphenyl metabolic function and novel microorganism having said exogenote bpha-c |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61282085A (en) |
-
1985
- 1985-06-08 JP JP60124555A patent/JPS61282085A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0336515B2 (en) | 1991-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| O’Sullivan et al. | Large scale production of cyclohexanone monooxygenase from Escherichia coli TOP10 pQR239 | |
| CN103497911B (en) | Application of Chryseobacterium sp. and carbonyl reductase thereof in production of aprepitant chiral intermediate | |
| CN101679963A (en) | Gene-disrupted strain, recombinant plasmid, transformant and method of producing 3-carboxymuconolactone | |
| CN106957850A (en) | Genetically engineered bacterium for producing phospholipase D and construction method and application thereof | |
| JP3408737B2 (en) | Protein involved in nitrile hydratase activation and gene encoding the same | |
| CN111454998B (en) | A kind of biopreparation method of chiral hydroxy acid ester | |
| RU2088667C1 (en) | Method of microbiological hydroxylation of methyl groups of aromatic 5- and 6-membered heterocycles, recombinant plasmid dna pl04, recombinant plasmid dna pl05, strain of microorganism escherichia coli used for producing hydroxymethyl derivatives of aromatic 5- or 6-membered heterocycles and strain of microorganism pseudomonas putida used for producing hydroxymethyl derivatives of aromatic 5- or 6-membered heterocycles | |
| JP2003531620A (en) | Site-specific insertion method in Zymomonas mobilis | |
| JPH0740936B2 (en) | Ascorbic acid intermediates and process enzymes | |
| CA2343970A1 (en) | Process for producing optically active pyridineethanol derivatives | |
| JPS61282085A (en) | Exogenote bpha-c having biphenyl metabolic function and novel microorganism having said exogenote bpha-c | |
| CN113249348B (en) | Carbonyl reductase, its gene, recombinant expression transformant containing the gene and application thereof | |
| US5308765A (en) | Esterase genes, esterase, recombinant plasmids and transformants containing the recombinant plasmid and methods of producing optically acitve carboxylic acids and their enantiomeric esters using said transformants | |
| CN116200352A (en) | 7α-Hydroxysteroid dehydrogenase mutants and their application in the synthesis of 7-oxo-lithocholic acid | |
| US5306625A (en) | Process for terminal hydroxylation of ethyl groups on aromatic 5- or 6-ring heterocycles | |
| JPH0336510B2 (en) | ||
| JPH0342071B2 (en) | ||
| JPS63157986A (en) | Production of l-phenylalanine by gene recombination | |
| JPH0559705B2 (en) | ||
| CN111690581A (en) | Method for producing ice nucleoprotein by recombinant escherichia coli fermentation | |
| US20070015236A1 (en) | Process of preparing prednisolone devoid of steroid-derived impurities using recombinant E. coli transformed with A delta¹-dehydrogenase gene | |
| FR2464999A1 (en) | METHOD FOR BUILDING A GENETIC ELEMENT DETERMINING THE PRODUCTION OF AN ENZYME | |
| JP2598718B2 (en) | Novel indole-3-pyruvate decarboxylase and method for producing the same | |
| JPH0468909B2 (en) | ||
| JPS63304985A (en) | Novel plasmid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |